Form 4: Royalty Pharma Director Hodgson Receives Stock Award

Director David C. Hodgson of Royalty Pharma plc reports the acquisition of 9,293 Class A Ordinary Shares through a restricted stock unit award.

Summary

• David C. Hodgson, a director of Royalty Pharma plc, reported a transaction on June 7, 2024.
• He acquired 9,293 Class A Ordinary Shares through an award of restricted stock units.
• These restricted stock units were granted under the Issuer's 2020 Independent Director Equity Incentive Plan.
• The units are scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date.
• Hodgson holds these units solely for the benefit of General Atlantic Service Company, L.P., and disclaims beneficial ownership.

Sentiment

Score: 7

Explanation: The document reflects a standard director compensation practice, indicating a stable and well-governed company. The sentiment is neutral to slightly positive.

Positives

• The award of restricted stock units aligns the director's interests with the company's performance.
• The vesting schedule encourages long-term commitment.

Future Outlook

The vesting of the restricted stock units is contingent upon the terms of the 2020 Independent Director Equity Incentive Plan and the applicable award agreement.

Industry Context

Stock awards to directors are a common practice in publicly traded companies to incentivize and align their interests with those of shareholders.

Comparison to Industry Standards

• Director compensation packages often include a mix of cash and equity.
• Equity awards, such as restricted stock units, are typically subject to vesting schedules based on time or performance.
• The size and structure of the award are generally benchmarked against peer companies in the pharmaceutical industry.

Stakeholder Impact

• The stock award aligns the director's interests with those of shareholders, potentially leading to better corporate governance and decision-making.

Key Dates